5 Stocks to Buy With Accelerating Sales and Earnings Growth
A new research note from Jefferies highlights companies that have seen accelerating sales and EPS growth over the past four quarters.
All Work
Lee Jackson
What the Top Fund Portfolio Managers Are Buying and Selling Now
A new research note from Jefferies indicates the top things fund portfolio managers are doing now, as well as what the analysts have gleaned from survey data.
UBS Has Just 5 Chip Stocks to Buy Now
A new report from UBS focuses in on just five semiconductor stocks for clients to consider now.
Stifel Calls a Bottom in These 5 Oil Stocks
According to Stifel, now is the time for investors to strongly consider buying some quality energy stocks.
The 10 Top US Wireless Trends for the Big 4 Carriers
A new report from UBS analysts highlights the 10 top trends in the U.S. wireless industry as of the end of 2014.
Americans Are Finally Making More Money, and 3 Retail Stocks Will Benefit
Jefferies analysts see three top retail stocks benefiting from rising wages and lower fuel prices.
Merrill Lynch Initiates High-Yield Oil Service Specialty MLPs at Buy
A new report from Merrill Lynch, instead of focusing on the big cap diversifieds, dives into a group of master limited partnerships (MLPs) that may produce solid oil beta.
4 Tech Stocks Benefiting From Huge Computer Services and IT Consulting Demand
A new report from the analysts at Cowen says that feedback they have received from the largest offshore information technology (IT) services players suggests solid demand trends.
Despite Intel’s Woes, 3 Chip Equipment Stocks Look Tempting
A new research report from UBS suggests that fears of a huge drop in Intel's capital expenditures (capex) may be unfounded.
6 Stocks Will See Massive Buying and Selling on S&P Quarterly Rebalance
All indexes rebalance on a quarterly basis. 24/7 Wall St. screened a recent Jefferies report for the stocks that will see the most trading on Friday's rebalance.
The 10 Most Frequently Asked Questions by Investors Now
Deutsche Bank cautions that a near-term correction could be in the offing, and that sector selection could be more important this year than in recent years.
Should Investors Buy These 4 ‘Bad News’ Stocks for Big Gains?
24/7 Wall St. has found four good examples of blue-chip stocks that got a little tarnished recently for one reason or another, that investors may want to reexamine.
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases.
Insider Selling Picks Up as Market Volatility Starts to Jump
While the selling that was reported this week was consistent with what we have seen so far in March, nothing indicates a mass exodus for shareholders at this point.
Insider Buying Solid Despite Roller-Coaster Market Volatility
This past week's trading was marked with huge up and down swings and a rise and fall in volatility. Generally, this is the kind of market action that makes strategists nervous.
3 Tech Stocks to Buy That Benefit From Huge Network Buildouts
Deutsche Bank analysts focused on three companies that stand to benefit from the continued effort by the carriers to build out network capacity.
UBS Dividend Ruler Stocks Keep Raising Dividend Payouts
A new report from the Dividend Ruler analysts at UBS highlights the many stocks in the current portfolio that have already raised dividends this year.
4 Tech Stocks That Will Be Affected by Slowing PC Sales
RBC analysts focused on four stocks that could also see an impact from the recent decline in PC sales.
Deutsche Bank Has 4 Internet Stocks to Buy
A new research note from Deutsche Bank focuses on some of the well-known, but lower profile Internet stocks that could be poised for big things.
Merrill Lynch Has 5 Stocks to Buy With Big Upcoming Catalysts
Here are five stocks on the Merrill Lynch SMID-Cap Alpha list that have some big news and events that may be right around the corner. All are rated Buy at Merrill Lynch.